Key result
Age correlates with hs-cTnT and hs-cTnI more than sex, with median differences only 1.9 ng/L.
Why the study?
The authors aimed to challenge the assumption that women have significantly lower troponin levels than men and evaluate whether the effect of age is underestimated.
Does age have a larger confounding effect than sex on high-sensitivity cardiac troponin T and I levels in cardiac-healthy individuals?
Observational (n=3,083)
Yes
Does age have a larger confounding effect than sex on high-sensitivity cardiac troponin T and I levels in cardiac-healthy individuals?
Sex-specific differences in high-sensitivity cardiac troponin concentrations are much smaller than currently assumed, while the effect of age is more substantial and should be incorporated into future diagnostic criteria.
May support revising sex-specific hs-cTn thresholds; challenges prior assumptions and leaves open prospective validation of age-adjusted criteria.
Introduction The clinical introduction of high sensitivity cardiac troponin (hs-cTn) assays has revolutionized myocardial infarction (MI) diagnosis, enabling earlier detection and better outcomes. The Fourth Universal Definition of MI (UDMI) sets the 99th percentile upper reference limit (URL) as a diagnostic threshold. Age as a possible confounder is ignored. Reported sex differences in the 99th percentile URL (hs-cTnT: 9 versus 16 ng/L; hs-cTnI: 16 versus 34 ng/L) suggest women have lower hs-cTn levels than men. Purpose We aimed to challenge the assumption of women having a significantly lower troponin level compared to men. Additionally, we hypothesized that the effect of age on troponin levels may be underestimated and could vary between sexes. Materials & Methods This secondary analysis included data from two large prospective diagnostic studies. Two independent cardiologists performed central adjudication based on extensive patient characterization including cardiac imaging and blinded measurements of hs-cTnT and hs-cTnI, to identify cardiac-healthy individuals. Further criteria included age under 75 years, no history of cardiovascular diseases, absence of relevant functional or structural abnormalities in cardiac imaging, no cardiovascular death or MI within two years of follow-up and exclusion of individuals with a N-terminal pro b-type natriuretic peptide (NT-proBNP) levels > 125 ng/L. The Dixon’s method was used to remove the hs-cTnT/I outliers. An adjusted quantile regression modeled the relation between hs-cTnT/I and the predictors age and sex. Results The cohort consists of 3’083 cardiac-healthy individuals, 1’154 women and 1’929 men. The difference in median hs-cTnT between women and men at age 60 was 1.9 ng/L, and at age 40, 1.1 ng/L. The difference in median hs-cTnI between women and men at age 60 and at age 40 was even smaller (0.6 ng/L vs. 0.8 ng/L). We observed similar findings for the 75th percentile for hs-cTnT and hs-cTnI. The confounding effect of age was larger than that of sex for both hs-cTnT and hs-cTnI. An independent external validation cohort confirmed these findings. Conclusion Sex-specific age-adjusted difference in median percentile for hs-cTn concentrations are considerably smaller than currently assumed, and much smaller than the effect of age. These important findings should inform future UDMI criteria and incorporate the effect of age.Median hs-cTnT (Age) Median hs-cTnI (Age)
No takes yet. Share an insight, caveat, or question.
Elavathingal et al. (2025) conducted an observational in Cardiac-healthy individuals (n=3,083). Female sex and increasing age vs. Male sex and younger age was evaluated on Median hs-cTnT and hs-cTnI concentrations. Female sex was associated with only small differences in median hs-cTnT (1.9 ng/L at age 60) and hs-cTnI (0.6 ng/L at age 60) compared to men, with age exerting a larger confounding effect.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: